PlainRecalls
FDA Drug Moderate Class II Terminated

PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.

Reported: August 22, 2018 Initiated: July 25, 2018 #D-1092-2018

Product Description

PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.

Reason for Recall

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Details

Units Affected
1 vial
Distribution
Product was distributed within the state of Pennsylvania.
Location
Jeannette, PA

Frequently Asked Questions

What product was recalled?
PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Injection, 18mcg/1.8 mg/0.2 mg/0.02 mg/mL, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.. Recalled by Ranier's Compounding Laboratory. Units affected: 1 vial.
Why was this product recalled?
Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 22, 2018. Severity: Moderate. Recall number: D-1092-2018.